https://www.healthcarefocusminnesota.com/article/911074025-silo-pharma-files-provisional-patent-for-ibogaine-based-therapeutic-targeting-traumatic-brain-injury Healthcare Focus Minnesota en PressRelease 2026-05-07T12:05:00+00:00 Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury https://ml.globenewswire.com/media/3b635464-4382-4b8b-8175-39cc32e08050/small/logo-png.png https://www.healthcarefocusminnesota.com/article/911074361-scienture-secures-11-0-million-in-non-dilutive-debt-financing-to-accelerate-growth-of-approved-product-portfolio-and-advancement-of-r-d-pipeline Healthcare Focus Minnesota en PressRelease 2026-05-07T12:05:00+00:00 Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline https://ml.globenewswire.com/media/aeec492f-ff8f-4be3-9000-faf012464b8d/small/logo-png.png https://www.healthcarefocusminnesota.com/article/911074473-ardelyx-presents-analysis-supporting-long-term-safety-of-xphozah-at-nkf-s-spring-clinical-meetings Healthcare Focus Minnesota en PressRelease 2026-05-07T12:01:00+00:00 Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings https://ml.globenewswire.com/media/cee4ae6d-7a85-44bf-9c02-87e7fa934ec2/small/ardelyx-logo-rgb-jpg.jpg https://www.healthcarefocusminnesota.com/article/911073685-krystal-biotech-to-present-at-bofa-securities-2026-health-care-conference Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 Krystal Biotech to Present at BofA Securities 2026 Health Care Conference https://ml.globenewswire.com/media/94ec1f39-c0eb-4e65-9d7e-250519ef03f4/small/krys-logo-nobackground-with-registered-symbol-png.png https://www.healthcarefocusminnesota.com/article/911073690-dar-bioscience-to-host-first-quarter-2026-financial-results-and-company-update-conference-call-and-webcast-on-may-14-2026 Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 Daré Bioscience to Host First Quarter 2026 Financial Results and Company Update Conference Call and Webcast on May 14, 2026 https://ml.globenewswire.com/media/deaaf9ba-24cc-4909-ab8d-1982b8b4e650/small/darebioscience-primarylogo-02-vertical-reg-orangebrown-wtrad.png https://www.healthcarefocusminnesota.com/article/911073714-vtv-therapeutics-to-participate-in-upcoming-may-investor-conferences Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 vTv Therapeutics to Participate in Upcoming May Investor Conferences https://ml.globenewswire.com/media/27198d2d-fdd5-4f74-8f54-7a9e5876e06d/small/vtv-therapeutics-color-jpg.jpg https://www.healthcarefocusminnesota.com/article/911073726-mbx-biosciences-reports-first-quarter-2026-financial-results-and-corporate-highlights Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 MBX Biosciences Reports First Quarter 2026 Financial Results and Corporate Highlights https://ml.globenewswire.com/media/5499b327-bce0-4a3f-96a7-04a38b68a99f/small/mbx-logos-final-full-jpg.jpg https://www.healthcarefocusminnesota.com/article/911073729-mediwound-to-report-first-quarter-2026-financial-results Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 MediWound to Report First Quarter 2026 Financial Results https://ml.globenewswire.com/media/55509183-b8b9-4da4-ae63-92c83760b5d9/small/mdwd-logo-jpg.jpg https://www.healthcarefocusminnesota.com/article/911073756-stryker-declares-an-0-88-per-share-quarterly-dividend Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 Stryker declares an $0.88 per share quarterly dividend https://ml.globenewswire.com/media/c24fe8bd-9db6-4f42-8a52-06a4e1b673b5/small/stryker-logo2015-jpg.jpg https://www.healthcarefocusminnesota.com/article/911073796-ars-pharmaceuticals-announces-conference-call-and-webcast-for-its-first-quarter-2026-financial-results Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2026 Financial Results https://ml.globenewswire.com/media/8feeb9d1-ed0c-491a-988b-a2b54778e825/small/ars-logo-png.png https://www.healthcarefocusminnesota.com/article/911073823-arrivent-announces-ind-clearance-for-novel-tetravalent-muc16-napi2b-targeting-adc-arr-002-with-initial-focus-in-ovarian-and-endometrial-cancers Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 ArriVent Announces IND Clearance for Novel Tetravalent MUC16/NaPi2b Targeting ADC ARR-002 with Initial Focus in Ovarian and Endometrial Cancers https://ml.globenewswire.com/media/fc6761bf-9c47-4e62-ba46-f7c10eefe6bc/small/arrivent-logo-final-png.png https://www.healthcarefocusminnesota.com/article/911073885-praxis-precision-medicines-provides-corporate-update-and-reports-first-quarter-2026-financial-results Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg https://www.healthcarefocusminnesota.com/article/911073907-solid-biosciences-doses-first-participant-in-phase-3-impact-duchenne-clinical-trial-evaluating-sgt-003-in-duchenne-muscular-dystrophy Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy https://ml.globenewswire.com/media/bb5e6b30-d9d9-464f-8c64-33a09eacc3fb/small/solid-1029x579-png.png https://www.healthcarefocusminnesota.com/article/911073946-prime-medicine-reports-first-quarter-2026-financial-results-and-provides-business-updates Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/ebddcf3b-2b71-4df6-99e8-d07617d9e327/small/prime-medicine-logo-approved-color-png.png https://www.healthcarefocusminnesota.com/article/911073955-alx-oncology-s-evorpacept-in-combination-with-zanidatamab-generates-promising-durable-response-in-patients-with-advanced-her2-positive-breast-cancer Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 ALX Oncology’s Evorpacept in Combination with Zanidatamab Generates Promising, Durable Response in Patients with Advanced HER2-Positive Breast Cancer and High CD47 Expression https://ml.globenewswire.com/media/0a1b4459-3df3-4c9f-ba29-ace8d7ad1b9a/small/alx-01-stacked-white-png.png https://www.healthcarefocusminnesota.com/article/911073980-filana-therapeutics-reports-q1-2026-financial-results-and-business-update Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 Filana Therapeutics Reports Q1 2026 Financial Results and Business Update https://ml.globenewswire.com/media/984a6554-2b2a-4cf7-9a32-72ac808d52ac/small/filana400-png.png https://www.healthcarefocusminnesota.com/article/911074087-celcuity-schedules-release-of-first-quarter-2026-financial-results-and-webcast-conference-call Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 Celcuity Schedules Release of First Quarter 2026 Financial Results and Webcast/Conference Call https://ml.globenewswire.com/media/dab74495-313f-47dd-a6cb-b42a7f024edd/small/celcuity-logo-rgb-jpg.jpg https://www.healthcarefocusminnesota.com/article/911074221-urogen-pharma-to-present-at-upcoming-investor-conferences Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 UroGen Pharma to Present at Upcoming Investor Conferences https://ml.globenewswire.com/media/8b4e2813-5822-438f-a0d8-1a2c99628858/small/urogen-logo2-r-002-png.png https://www.healthcarefocusminnesota.com/article/911074243-nrx-pharmaceuticals-nasdaq-nrxp-announces-fda-clearance-to-proceed-with-clinical-trial-of-nrx-101-in-combination-with-robotic-enabled-transcranial Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression and Suicidality https://ml.globenewswire.com/media/d879f1ff-d5d7-48d7-9731-c881b469d873/small/nrx-logo-300dpi-png.png https://www.healthcarefocusminnesota.com/article/911074297-aardvark-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-updates Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 Aardvark Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/8fed323c-8d04-4a71-bfb1-e38d23a29ec9/small/aardvark-logo-png.png https://www.healthcarefocusminnesota.com/article/911074338-askbio-announces-6-presentations-at-american-society-of-gene-and-cell-therapy-asgct-29th-annual-meeting Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 AskBio Announces 6 Presentations at American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting https://ml.globenewswire.com/media/ZDA1MzU5MWItOTRlZS00MTg4LTk5MTAtMjI5MzUzYjY3M2FmLTEyODY3MTItMjAyNi0wNS0wNy1lbg==/tiny/Asklepios-BioPharmaceutical-In.png https://www.healthcarefocusminnesota.com/article/911074385-serb-pharmaceuticals-announces-thyrosafe-130-mg-potassium-iodide-tablets-are-now-commercially-available-in-the-us Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 SERB Pharmaceuticals Announces ThyroSafe 130 mg Potassium Iodide Tablets are Now Commercially Available in the US https://ml.globenewswire.com/media/7862df2f-dd67-489b-973a-030c1c164344/small/serb-rgb-trimmed-png.png https://www.healthcarefocusminnesota.com/article/911074394-willis-knighton-health-selects-commure-as-enterprise-ambient-scribe-ai-partner Healthcare Focus Minnesota en PressRelease 2026-05-07T12:00:00+00:00 Willis Knighton Health Selects Commure as Enterprise Ambient Scribe AI Partner https://ml.globenewswire.com/media/1136e76f-ef70-46bf-997e-5f9b1b8b2ff6/small/commure-logo-full-horizontal-black-3-png.png https://www.healthcarefocusminnesota.com/article/911073790-vericel-reports-first-quarter-2026-financial-results-and-raises-full-year-financial-guidance Healthcare Focus Minnesota en PressRelease 2026-05-07T11:45:00+00:00 Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance https://ml.globenewswire.com/media/6a144258-8523-493f-8a1e-ccceec233208/small/vericel-corporation-logo.jpg https://www.healthcarefocusminnesota.com/article/911073583-edap-reports-strong-financial-results-with-record-first-quarter-hifu-revenue Healthcare Focus Minnesota en PressRelease 2026-05-07T11:30:00+00:00 EDAP Reports Strong Financial Results with Record First Quarter HIFU Revenue https://ml-eu.globenewswire.com/media/ded19329-9645-4860-ac2d-bf3e2422b649/small/focalone-square-logo-drkblue-web-400-1-png.png https://www.healthcarefocusminnesota.com/article/911073587-evaxion-announces-business-update-and-first-quarter-2026-financial-results Healthcare Focus Minnesota en PressRelease 2026-05-07T11:30:00+00:00 Evaxion announces business update and first quarter 2026 financial results https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png https://www.healthcarefocusminnesota.com/article/911073748-black-diamond-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update Healthcare Focus Minnesota en PressRelease 2026-05-07T11:30:00+00:00 Black Diamond Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/b8da4d92-789b-4f0a-a1e2-2739af370155/small/bdtxlogo-pantone3135c-png-png.png https://www.healthcarefocusminnesota.com/article/911073752-collegium-reports-first-quarter-2026-financial-results-and-highlights-recent-company-progress Healthcare Focus Minnesota en PressRelease 2026-05-07T11:30:00+00:00 Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress https://ml.globenewswire.com/media/c9077b27-1a69-42a5-9f77-e39124f4d2a2/small/collegium-rgb-large-r-jpg.jpg https://www.healthcarefocusminnesota.com/article/911073827-briacell-adds-nyu-langone-health-s-perlmutter-cancer-center-as-clinical-site-in-pivotal-phase-3-breast-cancer-study Healthcare Focus Minnesota en PressRelease 2026-05-07T11:30:00+00:00 BriaCell Adds NYU Langone Health’s Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study https://ml.globenewswire.com/media/88b9408d-31d4-4afd-beff-f855719a15d8/small/briacell-logo-square-a-jpg.jpg https://www.healthcarefocusminnesota.com/article/911073837-annovis-ceo-to-present-on-multi-protein-model-of-alzheimer-s-disease-at-fierce-biotech-week-2026 Healthcare Focus Minnesota en PressRelease 2026-05-07T11:30:00+00:00 Annovis CEO to Present on Multi-Protein Model of Alzheimer's Disease at Fierce Biotech Week 2026 https://ml.globenewswire.com/media/7ee459df-d33f-4f42-b27c-3bd20487d50c/small/annovis-corp-image-png.png https://www.healthcarefocusminnesota.com/article/911073910-repligen-corporation-to-present-at-bank-of-america-securities-2026-global-healthcare-conference Healthcare Focus Minnesota en PressRelease 2026-05-07T11:30:00+00:00 Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference https://ml.globenewswire.com/media/967d43f6-7ffd-4ee0-8804-e3c12952402f/small/repligen-logo-horizontal-withtagline-1-jpg.jpg https://www.healthcarefocusminnesota.com/article/911074002-vera-therapeutics-provides-business-update-and-reports-first-quarter-2026-financial-results Healthcare Focus Minnesota en PressRelease 2026-05-07T11:30:00+00:00 Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/b5c9081c-e6d9-44f7-abd0-0997a3c713f2/small/vera-thumbnail-jpg.jpg https://www.healthcarefocusminnesota.com/article/911074021-lexicon-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provides-clinical-updates Healthcare Focus Minnesota en PressRelease 2026-05-07T11:30:00+00:00 Lexicon Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Clinical Updates https://ml.globenewswire.com/media/afcf3b59-ca71-40ed-9226-a0901bf4d13b/small/logo-jpg.jpg https://www.healthcarefocusminnesota.com/article/911074035-plus-therapeutics-receives-medicare-enrollment-approval-for-cnside-diagnostic Healthcare Focus Minnesota en PressRelease 2026-05-07T11:30:00+00:00 Plus Therapeutics Receives Medicare Enrollment Approval for CNSide Diagnostic https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png https://www.healthcarefocusminnesota.com/article/911074164-palvella-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update Healthcare Focus Minnesota en PressRelease 2026-05-07T11:30:00+00:00 Palvella Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg https://www.healthcarefocusminnesota.com/article/911074373-harvard-bioscience-to-participate-in-upcoming-investor-conferences Healthcare Focus Minnesota en PressRelease 2026-05-07T11:30:00+00:00 Harvard Bioscience to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/6784a4a6-c259-489c-8b5b-05266f41b06f/small/hbio-logo-png.png https://www.healthcarefocusminnesota.com/article/911074444-ascendis-pharma-reports-first-quarter-2026-financial-results Healthcare Focus Minnesota en PressRelease 2026-05-07T11:30:00+00:00 Ascendis Pharma Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/b4b7c29a-478e-4a8e-b23b-b6a1cb18aee8/small/ascendis-final-logo-7-23-15-png.png https://www.healthcarefocusminnesota.com/article/911073817-kane-biotech-announces-new-private-placement-offering Healthcare Focus Minnesota en PressRelease 2026-05-07T11:25:00+00:00 Kane Biotech Announces New Private Placement Offering https://ml.globenewswire.com/media/a2ad1d52-1d5a-425c-93de-45cc52c3784b/small/kane-logo-cropped-transbg-png.png https://www.healthcarefocusminnesota.com/article/911074235-alterity-therapeutics-to-deliver-presentations-at-multiple-medical-conferences-in-may-2026 Healthcare Focus Minnesota en PressRelease 2026-05-07T11:25:00+00:00 Alterity Therapeutics to Deliver Presentations at Multiple Medical Conferences in May 2026 https://ml.globenewswire.com/media/0771a9a2-2ac1-4a63-9767-a2b1df74af27/small/alterity-png.png https://www.healthcarefocusminnesota.com/article/911074271-legacy-opens-pasadena-southmore-clinic-to-address-critical-health-care-needs Healthcare Focus Minnesota en PressRelease 2026-05-07T11:20:00+00:00 Legacy Opens Pasadena Southmore Clinic to Address Critical Health Care Needs https://ml.globenewswire.com/media/17d6ae9e-bb12-416e-96c0-afcce30b368e/medium/legacy-pasadena-southmore-clinic-ribbon-cutting.png https://www.healthcarefocusminnesota.com/article/911073999-aurora-spine-announces-issuance-of-fourth-u-s-patent-covering-dexa-technology-bone-density-matched-implants Healthcare Focus Minnesota en PressRelease 2026-05-07T11:15:00+00:00 Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology® Bone Density-Matched Implants https://ml.globenewswire.com/media/af1a0a7b-b883-41f9-8c86-a89bad3cc4a4/small/aurora12-jpg.JPG https://www.healthcarefocusminnesota.com/article/911073738-entrada-therapeutics-reports-first-quarter-2026-financial-results Healthcare Focus Minnesota en PressRelease 2026-05-07T11:10:00+00:00 Entrada Therapeutics Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png https://www.healthcarefocusminnesota.com/article/911074398-terrascend-reports-first-quarter-2026-financial-results Healthcare Focus Minnesota en PressRelease 2026-05-07T11:10:00+00:00 TerrAscend Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/3057ae6c-0bfe-49e0-90d4-66688bd859c8/small/picture1-png.png https://www.healthcarefocusminnesota.com/article/911074229-iovance-biotherapeutics-highlights-positive-first-quarter-2026-results-business-achievements-and-corporate-updates Healthcare Focus Minnesota en PressRelease 2026-05-07T11:05:00+00:00 Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates https://ml.globenewswire.com/media/d0986bd6-4603-4e31-8ed1-f23b3e123605/small/iovance-jpg.jpg https://www.healthcarefocusminnesota.com/article/911061951-invivyd-to-host-first-quarter-2026-financial-results-and-corporate-update-call-on-may-14-2026 Healthcare Focus Minnesota en PressRelease 2026-05-07T11:01:00+00:00 Invivyd to Host First Quarter 2026 Financial Results and Corporate Update Call on May 14, 2026 https://ml.globenewswire.com/media/7bf12f50-1073-4ce7-81ac-89426c07add3/small/untitled-design-2-png.png https://www.healthcarefocusminnesota.com/article/911061966-mbx-biosciences-announces-appointment-of-mark-soued-as-chief-commercial-officer-and-inducement-grant-award Healthcare Focus Minnesota en PressRelease 2026-05-07T11:00:00+00:00 MBX Biosciences Announces Appointment of Mark Soued as Chief Commercial Officer and Inducement Grant Award https://ml.globenewswire.com/media/b8b07cf9-9fda-4eb3-8581-f664b7c317b1/medium/mark-r-soued-mba.jpg https://www.healthcarefocusminnesota.com/article/911061977-foghorn-therapeutics-provides-first-quarter-2026-financial-and-corporate-update Healthcare Focus Minnesota en PressRelease 2026-05-07T11:00:00+00:00 Foghorn Therapeutics Provides First Quarter 2026 Financial and Corporate Update https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg https://www.healthcarefocusminnesota.com/article/911062005-monte-rosa-therapeutics-announces-first-quarter-2026-financial-results-and-business-updates Healthcare Focus Minnesota en PressRelease 2026-05-07T11:00:00+00:00 Monte Rosa Therapeutics Announces First Quarter 2026 Financial Results and Business Updates https://ml.globenewswire.com/media/20ed9999-454a-4e2a-aabc-217270a87d2d/small/mrtx-logo-primaryblue-4cp-jpg.jpg https://www.healthcarefocusminnesota.com/article/911062059-opus-genetics-completes-enrollment-in-cohort-1-of-phase-1-2-opgx-best1-gene-therapy-study Healthcare Focus Minnesota en PressRelease 2026-05-07T11:00:00+00:00 Opus Genetics Completes Enrollment in Cohort 1 of Phase 1/2 OPGx-BEST1 Gene Therapy Study https://ml.globenewswire.com/media/c8c9006e-0278-4c21-a78c-6da68677c067/medium/table-1.png https://www.healthcarefocusminnesota.com/article/911062063-climb-bio-reports-first-quarter-2026-financial-results-and-provides-business-updates Healthcare Focus Minnesota en PressRelease 2026-05-07T11:00:00+00:00 Climb Bio Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/2a42b557-6e44-4818-bfce-2238a05f2c43/small/climb-400x400-002-jpg.jpg https://www.healthcarefocusminnesota.com/article/911062068-akebia-therapeutics-reports-first-quarter-2026-financial-results-and-commercial-and-pipeline-highlights Healthcare Focus Minnesota en PressRelease 2026-05-07T11:00:00+00:00 Akebia Therapeutics Reports First Quarter 2026 Financial Results and Commercial and Pipeline Highlights https://ml.globenewswire.com/media/c7f3708e-3328-4668-95c6-e7646efd653a/small/akebia-logo-fullcolor-rgb-png.png https://www.healthcarefocusminnesota.com/article/911062079-weight-watchers-announces-first-quarter-2026-results Healthcare Focus Minnesota en PressRelease 2026-05-07T11:00:00+00:00 Weight Watchers Announces First Quarter 2026 Results https://ml.globenewswire.com/media/f435b439-7f75-4d2f-a6cc-0e4e2ed811ea/small/weightwatchers-wordmark-boldblue-png.png https://www.healthcarefocusminnesota.com/article/911062107-apyx-medical-corporation-reports-first-quarter-2026-financial-results Healthcare Focus Minnesota en PressRelease 2026-05-07T11:00:00+00:00 Apyx Medical Corporation Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/aa0687d3-ab28-4615-b1e7-ef6c6e2a5541/small/apyx-medical-logo-jpg.jpg https://www.healthcarefocusminnesota.com/article/911062151-neumora-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update Healthcare Focus Minnesota en PressRelease 2026-05-07T11:00:00+00:00 Neumora Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/48256578-6cd3-4332-bf9b-2f52cfa248b7/small/neumora-logo-jpg.jpg https://www.healthcarefocusminnesota.com/article/911062158-cullinan-therapeutics-provides-corporate-update-and-reports-first-quarter-2026-financial-results Healthcare Focus Minnesota en PressRelease 2026-05-07T11:00:00+00:00 Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/3f4113d3-b651-4c00-bd96-c1ff9384b1de/small/cullinan-logo-rgb-clr-png.png https://www.healthcarefocusminnesota.com/article/911062176-ligand-reports-first-quarter-2026-financial-results Healthcare Focus Minnesota en PressRelease 2026-05-07T11:00:00+00:00 Ligand Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/1fe91aa2-494e-4b30-89e8-cad771bbaabf/small/new-ligand-logo-png.png https://www.healthcarefocusminnesota.com/article/911062259-entrada-therapeutics-announces-positive-topline-results-from-cohort-1-of-participants-with-duchenne-muscular-dystrophy-treated-with-entr-601-44-in Healthcare Focus Minnesota en PressRelease 2026-05-07T11:00:00+00:00 Entrada Therapeutics Announces Positive Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study https://ml.globenewswire.com/media/85d2df5e-d704-4ac3-9f40-b22b777ab67a/medium/table-1.jpg https://www.healthcarefocusminnesota.com/article/911062265-newamsterdam-pharma-provides-corporate-update-and-reports-first-quarter-financial-results Healthcare Focus Minnesota en PressRelease 2026-05-07T11:00:00+00:00 NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results https://ml.globenewswire.com/media/f7b8b881-9461-4712-9965-707ed3bdd573/small/newamsterdam-logo-full-color-final-png.png https://www.healthcarefocusminnesota.com/article/911062298-axsome-therapeutics-recognizes-mental-health-month Healthcare Focus Minnesota en PressRelease 2026-05-07T11:00:00+00:00 Axsome Therapeutics Recognizes Mental Health Month https://ml.globenewswire.com/media/1186f248-bfb6-4258-a391-f2ffd94c5d76/small/axsome-r-morpheus-logo-pos-rgb-png.png https://www.healthcarefocusminnesota.com/article/911062299-korro-reports-first-quarter-2026-financial-results-and-provides-corporate-update Healthcare Focus Minnesota en PressRelease 2026-05-07T11:00:00+00:00 Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/d49fc3c4-5cf6-4b89-8434-2eadfff25c26/small/korro-logo-rgb-jpg.jpg https://www.healthcarefocusminnesota.com/article/911062398-rapport-therapeutics-reports-first-quarter-2026-financials-and-provides-business-update Healthcare Focus Minnesota en PressRelease 2026-05-07T11:00:00+00:00 Rapport Therapeutics Reports First Quarter 2026 Financials and Provides Business Update https://ml.globenewswire.com/media/7777ee9b-f88b-4a59-a668-d81520f9d32c/small/rapport-logo-color-rgb-png.png https://www.healthcarefocusminnesota.com/article/911062411-widmer-brothers-launches-stay-sunny-campaign-a-full-brand-refresh-across-its-portfolio Healthcare Focus Minnesota en PressRelease 2026-05-07T11:00:00+00:00 Widmer Brothers Launches “Stay Sunny” Campaign, a Full Brand Refresh Across Its Portfolio https://ml.globenewswire.com/media/98e5e8a1-f11b-4416-ad47-b03fba5a6d50/medium/widmer-brothers-family-photos.png https://www.healthcarefocusminnesota.com/article/911062496-asimov-completes-lead-optimization-campaign-with-mabylon-ag-to-advance-trispecific-antibody-for-tree-pollen-allergies Healthcare Focus Minnesota en PressRelease 2026-05-07T11:00:00+00:00 Asimov Completes Lead Optimization Campaign with Mabylon AG to Advance Trispecific Antibody for Tree Pollen Allergies https://ml.globenewswire.com/media/0db01792-5780-4377-a289-8872f29ba02f/small/asimov-company-logo-png.png https://www.healthcarefocusminnesota.com/article/911061992-aclaris-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-and-clinical-update Healthcare Focus Minnesota en PressRelease 2026-05-07T10:59:00+00:00 Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update https://ml.globenewswire.com/media/de2bcb21-de59-4226-bc8b-b1b747461f51/small/aclaris-logo-clr-jpg.jpg https://www.healthcarefocusminnesota.com/article/911061943-biontech-k-ndigt-neues-r-ckkaufprogramm-f-r-american-depositary-shares-an Healthcare Focus Minnesota en PressRelease 2026-05-07T10:45:00+00:00 BioNTech kündigt neues Rückkaufprogramm für American Depositary Shares an https://ml-eu.globenewswire.com/media/b9e2e00e-f790-4d54-a01f-4c85716b01bd/small/ https://www.healthcarefocusminnesota.com/article/911061945-biontech-announces-new-ads-repurchase-program Healthcare Focus Minnesota en PressRelease 2026-05-07T10:45:00+00:00 BioNTech Announces New ADS Repurchase Program https://ml-eu.globenewswire.com/media/b9e2e00e-f790-4d54-a01f-4c85716b01bd/small/190705-biontech-logo-rgb-dark-green-preferred-0-png.png https://www.healthcarefocusminnesota.com/article/911062029-fennec-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-may-14-2026 Healthcare Focus Minnesota en PressRelease 2026-05-07T10:36:00+00:00 Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026 https://ml.globenewswire.com/media/2eeb9b85-0beb-4bbe-a7af-1c0e9403db44/small/fennec-logo-png.png https://www.healthcarefocusminnesota.com/article/911062084-shattuck-labs-reports-first-quarter-2026-financial-results-and-recent-business-highlights Healthcare Focus Minnesota en PressRelease 2026-05-07T10:15:00+00:00 Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/7f3ae7f0-9da7-487d-bb04-6c116f345054/small/shattuck-logo-dark-h-png.png https://www.healthcarefocusminnesota.com/article/911061957-maple-unveils-new-brand-vision-as-75-of-canadians-with-chronic-conditions-say-health-care-isn-t-working-for-them Healthcare Focus Minnesota en PressRelease 2026-05-07T10:03:00+00:00 Maple Unveils New Brand Vision as 75% of Canadians with Chronic Conditions Say Health Care Isn’t Working for Them https://ml.globenewswire.com/media/dda57c2b-7963-4bbc-bcc7-3df6ec36c60f/small/maple-logo-nomark-1c-green-p5605c-rgb-png.png https://www.healthcarefocusminnesota.com/article/911062098-enovis-announces-first-quarter-2026-results Healthcare Focus Minnesota en PressRelease 2026-05-07T10:01:00+00:00 Enovis Announces First Quarter 2026 Results https://ml.globenewswire.com/media/b4532895-c0b7-4f6a-9a37-db4eefc89e3d/small/logo-enovis-jpg.jpg https://www.healthcarefocusminnesota.com/article/911061940-lift-biosciences-establishes-scientific-advisory-board-to-accelerate-development-of-neutrophil-based-cancer-therapies Healthcare Focus Minnesota en PressRelease 2026-05-07T10:00:00+00:00 LIfT Biosciences Establishes Scientific Advisory Board to Accelerate Development of Neutrophil-based Cancer Therapies https://ml-eu.globenewswire.com/media/de6a30f1-b2fb-4208-a4c8-e53b2c2184dc/small/lift-biosciences-logo-side-on-final-upscale-png.png https://www.healthcarefocusminnesota.com/article/911061986-privia-health-reports-first-quarter-2026-financial-results Healthcare Focus Minnesota en PressRelease 2026-05-07T10:00:00+00:00 Privia Health Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/cbd80725-9c2b-43fd-8212-65414fe6bc0e/small/priv-jpg.jpg https://www.healthcarefocusminnesota.com/article/911062276-lifestance-reports-first-quarter-2026-results Healthcare Focus Minnesota en PressRelease 2026-05-07T10:00:00+00:00 LifeStance Reports First Quarter 2026 Results https://ml.globenewswire.com/media/08b345f0-a6a4-4217-9255-cce40df2585c/small/lifestance-logo-png.png https://www.healthcarefocusminnesota.com/article/911062285-gyre-therapeutics-reports-first-quarter-2026-results-and-provides-business-update Healthcare Focus Minnesota en PressRelease 2026-05-07T10:00:00+00:00 Gyre Therapeutics Reports First Quarter 2026 Results and Provides Business Update https://ml.globenewswire.com/media/24951768-57e9-4d7a-b969-f00258b17136/small/gyre-logo-png.png https://www.healthcarefocusminnesota.com/article/911062373-aclarion-announces-addition-of-first-private-practice-site-in-los-angeles-into-clarity-trial-to-further-accelerate-enrollment Healthcare Focus Minnesota en PressRelease 2026-05-07T10:00:00+00:00 Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment https://ml.globenewswire.com/media/6650177f-80b7-4c94-afb4-fc63aa3ada98/small/logo-png.png https://www.healthcarefocusminnesota.com/article/911051181-moongrade-releases-astrology-app-designed-to-deliver-personalized-birth-charts-and-unlimited-compatibility-insights Healthcare Focus Minnesota en PressRelease 2026-05-07T09:50:21+00:00 Moongrade Releases Astrology App Designed to Deliver Personalized Birth Charts and Unlimited Compatibility Insights https://ml-eu.globenewswire.com/media/70c40439-ffb1-4e55-af05-d867f9bfff0e/medium/exploring-compatibility-on-moongrade.png https://www.healthcarefocusminnesota.com/article/911051243-most-vision-loss-is-preventable-20-eye-care-neurology-and-integrative-medicine-experts-unite-for-free-global-summit-this-may Healthcare Focus Minnesota en PressRelease 2026-05-07T09:16:00+00:00 Most Vision Loss Is Preventable—20+ Eye Care, Neurology and Integrative Medicine Experts Unite for Free Global Summit This May https://ml.globenewswire.com/media/71089e9b-815c-4aca-9791-b1278cd81fc7/medium/the-eye-summit-2026-registration-flyer.jpg https://www.healthcarefocusminnesota.com/article/911051172-oculis-announces-agreement-with-fda-on-a-special-protocol-assessment-spa-for-optic-neuritis-registrational-trial Healthcare Focus Minnesota en PressRelease 2026-05-07T08:57:22+00:00 Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial https://ml-eu.globenewswire.com/media/f6fa6e90-83a4-4baa-a3b6-5483017d26b9/small/oculis-logo-gradient-jpg-resized-jpg.jpg https://www.healthcarefocusminnesota.com/article/910884155-david-hoy-associates-expands-golden-valley-and-chaska-mental-health-counselors-team Healthcare Focus Minnesota en PressRelease 2026-05-06T20:30:54+00:00 David Hoy & Associates Expands Golden Valley and Chaska Mental Health Counselors Team https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24849404-david-hoy-associates-new-logo-1200x628.png https://www.healthcarefocusminnesota.com/article/911039649-scarlet-therapeutics-demonstrates-in-vivo-survival-of-lab-grown-universal-red-blood-cells-equivalent-to-donated-blood Healthcare Focus Minnesota en PressRelease 2026-05-07T08:00:00+00:00 Scarlet Therapeutics Demonstrates In Vivo Survival of Lab-Grown Universal Red Blood Cells Equivalent to Donated Blood https://ml.globenewswire.com/media/c8c875ef-372a-4842-ba98-ce97dbc2acae/small/scarlet-logo-png.png https://www.healthcarefocusminnesota.com/article/911039661-tomi-environmental-solutions-nasdaq-tomz-clarifies-previously-announced-120m-preferred-stock-loi-to-merge-with-carbonium-core-entering-u-s Healthcare Focus Minnesota en PressRelease 2026-05-07T08:00:00+00:00 TOMI Environmental Solutions (Nasdaq: TOMZ) Clarifies Previously Announced $120M Preferred Stock LOI to Merge with Carbonium Core, Entering U.S. Nuclear-Grade Graphite Market for Advanced Reactors Within a $13–15B Global Graphite Industry https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://www.healthcarefocusminnesota.com/article/911028464-vianautis-bio-to-present-its-targeted-polynaut-nanovesicles-tpnvs-for-the-generation-of-in-vivo-car-t-therapies-at-asgct-annual-meeting Healthcare Focus Minnesota en PressRelease 2026-05-07T07:30:00+00:00 ViaNautis Bio to present its targeted polyNaut® nanovesicles (tPNVs) for the generation of in vivo CAR-T therapies at ASGCT Annual Meeting https://ml-eu.globenewswire.com/media/18ddcc44-b278-4873-b005-3dadd69c840e/small/vianautis-brandline-hoz-colour-png.png https://www.healthcarefocusminnesota.com/article/911028478-angelini-pharma-to-acquire-catalyst-pharmaceuticals-for-4-1-billion-usd-3-5-billion-euros-entering-the-u-s-market-and-consolidating-its-leadership Healthcare Focus Minnesota en PressRelease 2026-05-07T07:25:34+00:00 Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease https://ml-eu.globenewswire.com/media/f92dd6a5-1eab-49ca-94ea-b94225630a57/small/ml-angelini-pharma-colore-rgb-1-jpg.jpg https://www.healthcarefocusminnesota.com/article/911016894-catalyst-pharmaceuticals-announces-settlement-of-firdapse-amifampridine-patent-litigation-with-hetero-labs-ltd Healthcare Focus Minnesota en PressRelease 2026-05-07T06:44:12+00:00 Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Hetero Labs Ltd. https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg https://www.healthcarefocusminnesota.com/article/911016895-angelini-pharma-to-acquire-catalyst-pharmaceuticals-for-4-1-billion-usd-3-5-billion-euros-entering-the-u-s-market-and-consolidating-its-leadership Healthcare Focus Minnesota en PressRelease 2026-05-07T06:14:01+00:00 Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease https://ml-eu.globenewswire.com/media/f92dd6a5-1eab-49ca-94ea-b94225630a57/small/ml-angelini-pharma-colore-rgb-1-jpg.jpg https://www.healthcarefocusminnesota.com/article/911006722-zealand-pharma-execution-framework-for-share-buy-back-program Healthcare Focus Minnesota en PressRelease 2026-05-07T05:05:00+00:00 Zealand Pharma - Execution framework for share buy-back program https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://www.healthcarefocusminnesota.com/article/911006730-pharming-group-announces-presentations-at-cis-2026-annual-meeting-including-leniolisib-pediatric-data-in-apds-and-clinical-experience-in-cvid-and Healthcare Focus Minnesota en PressRelease 2026-05-07T05:05:00+00:00 Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders https://ml-eu.globenewswire.com/media/f164672f-d67c-41d2-9c79-46caee419077/small/logo-pharming-original-png.png https://www.healthcarefocusminnesota.com/article/911006705-zealand-pharma-announces-financial-results-for-the-first-three-months-of-2026 Healthcare Focus Minnesota en PressRelease 2026-05-07T05:00:00+00:00 Zealand Pharma Announces Financial Results for the First Three Months of 2026 https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://www.healthcarefocusminnesota.com/article/911006725-pharming-group-reports-first-quarter-2026-financial-results-on-track-for-joenja-u-s-pediatric-label-expansion-and-launches-in-japan-and-europe-in Healthcare Focus Minnesota en PressRelease 2026-05-07T05:00:00+00:00 Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026 https://ml-eu.globenewswire.com/media/f164672f-d67c-41d2-9c79-46caee419077/small/logo-pharming-original-png.png https://www.healthcarefocusminnesota.com/article/911006734-kuros-biosciences-appoints-i-v-hall-as-chief-operating-officer-deepening-operational-r-d-and-extremities-leadership-for-next-phase-of-growth Healthcare Focus Minnesota en PressRelease 2026-05-07T05:00:00+00:00 Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth https://ml-eu.globenewswire.com/media/ad3777c9-af1f-4b09-a899-3b3d6b8e962d/small/kuros-logo-jpg.jpg https://www.healthcarefocusminnesota.com/article/911006740-argenx-reports-first-quarter-2026-financial-results-and-provides-business-update Healthcare Focus Minnesota en PressRelease 2026-05-07T05:00:00+00:00 argenx Reports First Quarter 2026 Financial Results and Provides Business Update https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png https://www.healthcarefocusminnesota.com/article/911006717-zealand-pharma-initiates-usd-200-million-dkk-1-3-billion-share-buy-back-program Healthcare Focus Minnesota en PressRelease 2026-05-07T04:55:00+00:00 Zealand Pharma initiates USD 200 million / DKK 1.3 billion share buy-back program https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://www.healthcarefocusminnesota.com/article/910996354-suja-life-announces-pricing-of-initial-public-offering Healthcare Focus Minnesota en PressRelease 2026-05-07T04:16:42+00:00 Suja Life Announces Pricing of Initial Public Offering https://ml.globenewswire.com/media/9022887d-dd69-416f-9a4b-ce5e546d75e4/small/suja-life-horizontal-black-1-png.png https://www.healthcarefocusminnesota.com/article/910985412-steelpower-male-enhancement-ingredient-research-gains-attention-amongst-men-for-powerful-performance-support Healthcare Focus Minnesota en PressRelease 2026-05-07T03:18:50+00:00 SteelPower Male Enhancement Ingredient Research Gains Attention Amongst Men for Powerful Performance Support https://zingfast.com/wp-content/uploads/2026/05/SteelPower-Male-Enhancement-Reviews-Overview.jpg https://www.healthcarefocusminnesota.com/article/910985375-cytokinetics-announces-pricing-of-upsized-public-offering-of-common-stock Healthcare Focus Minnesota en PressRelease 2026-05-07T03:00:00+00:00 Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.healthcarefocusminnesota.com/article/910973660-innocare-announces-approval-of-clinical-trial-of-novel-cdh7-targeted-adc-icp-b208-in-china Healthcare Focus Minnesota en PressRelease 2026-05-07T02:25:13+00:00 InnoCare Announces Approval of Clinical Trial of Novel CDH7 targeted ADC ICP-B208 in China https://ml.globenewswire.com/media/2dc70b00-a0b0-4d85-adef-2717a7067aec/small/innocare-eng-logo-horizontal-png.png https://www.healthcarefocusminnesota.com/article/910960902-scynexis-announces-inducement-awards-under-nasdaq-listing-rule-5635-c-4 Healthcare Focus Minnesota en PressRelease 2026-05-07T01:15:28+00:00 SCYNEXIS Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/4171e010-3103-4d21-b1c5-5b1c27927dce/small/scyxprimarysmall-png.png https://www.healthcarefocusminnesota.com/article/910934658-ballad-health-academy-welcomes-second-class-of-students-amid-new-program-offerings-and-expansions Healthcare Focus Minnesota en PressRelease 2026-05-06T23:18:11+00:00 Ballad Health Academy welcomes second class of students amid new program offerings and expansions https://ml.globenewswire.com/media/NjgyOWVlMDktZGE4Ni00YWQ0LWJjMDUtODJkNmYxMTMwM2Q4LTExMzUxNTItMjAyNi0wNS0wNi1lbg==/tiny/Ballad-Health.png https://www.healthcarefocusminnesota.com/article/910934585-insuleaf-claims-evaluated-the-safer-more-effective-than-glp-1-drugs-natural-leak-peak-formula Healthcare Focus Minnesota en PressRelease 2026-05-06T22:51:42+00:00 InsuLeaf Claims Evaluated: The Safer & More Effective than GLP-1 Drugs, Natural Leak Peak Formula https://zingfast.com/wp-content/uploads/2026/05/InsuLeaf.jpg https://www.healthcarefocusminnesota.com/article/910934591-tomi-environmental-solutions-inc-to-hold-conference-call-to-discuss-first-quarter-2026-financial-results-on-may-8-2026 Healthcare Focus Minnesota en PressRelease 2026-05-06T22:50:09+00:00 TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss First Quarter 2026 Financial Results on May 8, 2026 https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://www.healthcarefocusminnesota.com/article/910920703-memora-claims-evaluated-new-memory-health-report-examines-advanced-brain-health-supplement-for-preventing-cognitive-decline Healthcare Focus Minnesota en PressRelease 2026-05-06T22:01:15+00:00 Memora Claims Evaluated: New Memory Health Report Examines Advanced Brain Health Supplement for Preventing Cognitive Decline https://zingfast.com/wp-content/uploads/2026/05/Memora.jpg https://www.healthcarefocusminnesota.com/article/910920657-totus-medicines-presents-early-phase-1b-clinical-data-demonstrating-100-disease-control-rate-and-class-leading-safety-for-tos-358-fulvestrant Healthcare Focus Minnesota en PressRelease 2026-05-06T22:00:00+00:00 Totus Medicines Presents Early Phase 1b Clinical Data Demonstrating 100% Disease Control Rate and Class-Leading Safety for TOS-358 + Fulvestrant Doublet Therapy in HR+/HER2- Breast Cancer at ESMO Breast Cancer Annual Congress 2026 https://ml.globenewswire.com/media/3eba21cf-0a86-45b2-a9f6-405a8ffbe407/small/totus-modularlogo-orange-01-50-jpg.jpg https://www.healthcarefocusminnesota.com/article/910920667-revolution-medicines-announces-publication-in-new-england-journal-of-medicine-of-phase-1-2-clinical-data-on-daraxonrasib-in-pancreatic-cancer Healthcare Focus Minnesota en PressRelease 2026-05-06T22:00:00+00:00 Revolution Medicines Announces Publication in New England Journal of Medicine of Phase 1/2 Clinical Data on Daraxonrasib in Pancreatic Cancer https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://www.healthcarefocusminnesota.com/article/910907210-gala-health-under-investigation-high-quality-compounded-glp-1-weight-loss-hormone-therapy-hrt-support Healthcare Focus Minnesota en PressRelease 2026-05-06T21:09:25+00:00 Gala Health Under Investigation: High-Quality Compounded GLP-1 Weight Loss & Hormone Therapy HRT Support https://zingfast.com/wp-content/uploads/2026/05/Gala-Health.jpg https://www.healthcarefocusminnesota.com/article/910907199-alpha-honey-gummies-claims-evaluated-the-alphahoney-male-enhancement-ingredients-for-virility-enhancing-performance-support Healthcare Focus Minnesota en PressRelease 2026-05-06T21:09:02+00:00 Alpha Honey Gummies Claims Evaluated: The AlphaHoney Male Enhancement Ingredients for Virility-Enhancing Performance Support https://zingfast.com/wp-content/uploads/2026/05/Alpha-Honey-Gummies.jpg https://www.healthcarefocusminnesota.com/article/910907183-supernus-pharmaceuticals-to-participate-in-the-bank-of-america-2026-health-care-conference Healthcare Focus Minnesota en PressRelease 2026-05-06T21:00:52+00:00 Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference https://ml.globenewswire.com/media/1fc58442-511b-40c2-a8c0-f1e78b8437b4/small/supernus-pharmaceuticals-inc.jpg https://www.healthcarefocusminnesota.com/article/910906890-precipio-announces-q1-2026-shareholder-update-call Healthcare Focus Minnesota en PressRelease 2026-05-06T21:00:00+00:00 Precipio Announces Q1-2026 Shareholder Update Call https://ml.globenewswire.com/media/d80ae417-b29a-4736-afa2-0f5e3beae51b/small/prpo-logo-png.png https://www.healthcarefocusminnesota.com/article/910906946-sanuwave-will-host-a-conference-call-on-may-13-2026-at-8-30-am-et-to-present-q1-2026-financial-results Healthcare Focus Minnesota en PressRelease 2026-05-06T21:00:00+00:00 Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results https://ml.globenewswire.com/media/6e709528-90af-4ff5-a08a-c0ea5a2cd4ab/small/sanuwave-logo-002-png.png https://www.healthcarefocusminnesota.com/article/910907154-vireo-growth-inc-to-release-first-quarter-results-on-may-12-2026 Healthcare Focus Minnesota en PressRelease 2026-05-06T20:57:08+00:00 Vireo Growth Inc. to Release First Quarter Results on May 12, 2026 https://ml.globenewswire.com/media/d01c0dca-8260-48c8-8ead-e09111cf57b5/small/vireo-horizontalllogolockup-01-png.png https://www.healthcarefocusminnesota.com/article/910894698-argenx-to-present-at-bofa-securities-2026-health-care-conference Healthcare Focus Minnesota en PressRelease 2026-05-06T20:30:00+00:00 argenx to Present at BofA Securities 2026 Health Care Conference https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png https://www.healthcarefocusminnesota.com/article/910894836-alvotech-q1-2026-financial-results Healthcare Focus Minnesota en PressRelease 2026-05-06T20:30:00+00:00 Alvotech Q1 2026 Financial Results https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg https://www.healthcarefocusminnesota.com/article/910894898-entrada-therapeutics-to-announce-topline-results-from-cohort-1-of-participants-with-duchenne-muscular-dystrophy-treated-with-entr-601-44-in-phase-1-2 Healthcare Focus Minnesota en PressRelease 2026-05-06T20:30:00+00:00 Entrada Therapeutics to Announce Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study on May 7, 2026 https://ml.globenewswire.com/media/77a7db51-bcfe-41a6-b2b5-9b281921f81c/small/entrada-logo-png.png https://www.healthcarefocusminnesota.com/article/910895166-ultragenyx-to-participate-at-bank-of-america-s-2026-healthcare-conference Healthcare Focus Minnesota en PressRelease 2026-05-06T20:30:00+00:00 Ultragenyx to Participate at Bank of America’s 2026 Healthcare Conference https://ml.globenewswire.com/media/121a9bda-7a64-41f8-85e8-1693a2dfa977/small/ultragenyx-cmyk-png.png https://www.healthcarefocusminnesota.com/article/910895508-bionano-announces-leadership-transition Healthcare Focus Minnesota en PressRelease 2026-05-06T20:30:00+00:00 Bionano Announces Leadership Transition https://ml.globenewswire.com/media/5ba4072e-6e59-46e7-847c-6aaf7755bbbf/small/bionano-rgb-png.png https://www.healthcarefocusminnesota.com/article/910895826-context-therapeutics-reports-first-quarter-2026-operating-and-financial-results Healthcare Focus Minnesota en PressRelease 2026-05-06T20:18:04+00:00 Context Therapeutics Reports First Quarter 2026 Operating and Financial Results https://ml.globenewswire.com/media/67b45666-397e-4c48-af45-ffd653bbfddf/small/context-therapeutics-inc.jpg https://www.healthcarefocusminnesota.com/article/910894880-precision-optics-schedules-third-quarter-of-fiscal-year-2026-conference-call-for-may-13-2026 Healthcare Focus Minnesota en PressRelease 2026-05-06T20:15:00+00:00 Precision Optics Schedules Third Quarter of Fiscal Year 2026 Conference Call for May 13, 2026 https://ml.globenewswire.com/media/6d86ce33-7e41-41e5-90b0-1c74cd89785e/small/precision-optics-logo-jpg.jpg https://www.healthcarefocusminnesota.com/article/910895493-dlh-reports-fiscal-2026-second-quarter-results Healthcare Focus Minnesota en PressRelease 2026-05-06T20:15:00+00:00 DLH Reports Fiscal 2026 Second Quarter Results https://ml.globenewswire.com/media/4efe5f34-0462-4275-ac88-2c8a07c2a9b0/small/dlh-logo-jpg.jpg https://www.healthcarefocusminnesota.com/article/910895725-rapid-micro-biosystems-to-announce-first-quarter-2026-financial-results-on-may-13-2026 Healthcare Focus Minnesota en PressRelease 2026-05-06T20:15:00+00:00 Rapid Micro Biosystems to Announce First Quarter 2026 Financial Results on May 13, 2026 https://ml.globenewswire.com/media/12585575-0b2e-4369-bf15-500b17ccb859/small/rapid-micro-biosystems-logo.png https://www.healthcarefocusminnesota.com/article/910895755-biomx-s-zorronet-puts-full-ai-command-and-control-in-the-palm-of-your-hand Healthcare Focus Minnesota en PressRelease 2026-05-06T20:15:00+00:00 BiomX’s Zorronet Puts Full AI Command-and-Control in the Palm of Your Hand https://ml.globenewswire.com/media/MmRlYTBjOWQtOTQ1ZS00ZmI2LWFlNmUtOThmNmFkMzZhNjNjLTEzMjE4NzEtMjAyNi0wNS0wNi1lbg==/tiny/BiomX.png https://www.healthcarefocusminnesota.com/article/910894744-inspiremd-to-participate-in-upcoming-bank-of-america-securities-2026-global-healthcare-conference Healthcare Focus Minnesota en PressRelease 2026-05-06T20:05:00+00:00 InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference https://ml-eu.globenewswire.com/media/5aefda10-5578-41c7-a1c0-9c4b700687c0/small/inspiremd-jpg.jpg https://www.healthcarefocusminnesota.com/article/910894871-imdx-to-release-first-quarter-2026-results-on-may-13-2026 Healthcare Focus Minnesota en PressRelease 2026-05-06T20:05:00+00:00 iMDx to Release First Quarter 2026 Results on May 13, 2026 https://ml.globenewswire.com/media/418fe8d1-a6a4-4025-84ba-56f14ee83865/small/imdx-logo-png.png https://www.healthcarefocusminnesota.com/article/910894872-electrocore-announces-first-quarter-2026-financial-results Healthcare Focus Minnesota en PressRelease 2026-05-06T20:05:00+00:00 electroCore Announces First Quarter 2026 Financial Results https://ml.globenewswire.com/media/b80ed5b6-a449-461c-9034-85386286b09d/small/ec-logo-2018-tm-cmyk-jpg.jpg https://www.healthcarefocusminnesota.com/article/910894884-surrozen-reports-first-quarter-2026-financial-results-and-provides-business-update Healthcare Focus Minnesota en PressRelease 2026-05-06T20:05:00+00:00 Surrozen Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/f8766f36-378a-41ad-9256-3cf0ca847440/small/logoonly-png.png https://www.healthcarefocusminnesota.com/article/910895148-vaxcyte-reports-first-quarter-2026-financial-results-and-provides-business-update Healthcare Focus Minnesota en PressRelease 2026-05-06T20:05:00+00:00 Vaxcyte Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg https://www.healthcarefocusminnesota.com/article/910895158-sight-sciences-reports-first-quarter-2026-financial-results-and-raises-full-year-2026-revenue-guidance Healthcare Focus Minnesota en PressRelease 2026-05-06T20:05:00+00:00 Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance https://ml.globenewswire.com/media/e7536623-9fa4-42d0-896d-04ddb984ef4e/small/sght-logo-png.png https://www.healthcarefocusminnesota.com/article/910895170-mineralys-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update Healthcare Focus Minnesota en PressRelease 2026-05-06T20:05:00+00:00 Mineralys Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/2f3e6873-8e64-406e-832e-7df0f6d79a56/small/mineralys-therapeutics-logo-jpg.jpg https://www.healthcarefocusminnesota.com/article/910895217-lifemd-reports-first-quarter-2026-results Healthcare Focus Minnesota en PressRelease 2026-05-06T20:05:00+00:00 LifeMD Reports First Quarter 2026 Results https://ml.globenewswire.com/media/07c92c99-5645-4be8-a3b7-6d9392b7ccc4/small/lifemd-png.png https://www.healthcarefocusminnesota.com/article/910895221-rxsight-inc-reports-first-quarter-2026-results-and-reiterates-full-year-sales-outlook Healthcare Focus Minnesota en PressRelease 2026-05-06T20:05:00+00:00 RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook https://ml.globenewswire.com/media/48441335-c938-45ff-9355-ba8e331354e9/small/rxsight-globe-png.png https://www.healthcarefocusminnesota.com/article/910895226-clover-health-reports-first-quarter-2026-results Healthcare Focus Minnesota en PressRelease 2026-05-06T20:05:00+00:00 Clover Health Reports First Quarter 2026 Results https://ml.globenewswire.com/media/1a48a25b-b654-4d62-adb3-d1a776346264/small/clover-logo-green-rgb-jpg.jpg https://www.healthcarefocusminnesota.com/article/910895228-zevra-reports-first-quarter-2026-financial-results-and-corporate-update Healthcare Focus Minnesota en PressRelease 2026-05-06T20:05:00+00:00 Zevra Reports First Quarter 2026 Financial Results and Corporate Update https://ml.globenewswire.com/media/cf39ab90-8c07-407d-a7ea-b7c9d48d44c4/small/zevra-inline-fullcolor-rgb-12in-300ppi-1-png.png https://www.healthcarefocusminnesota.com/article/910895272-tarsus-reports-first-quarter-2026-financial-results-and-recent-business-achievements Healthcare Focus Minnesota en PressRelease 2026-05-06T20:05:00+00:00 Tarsus Reports First Quarter 2026 Financial Results and Recent Business Achievements https://ml.globenewswire.com/media/22d429f7-9b81-4c03-a147-1d9cbc86d1dd/small/tarsus-logo-stacked-color-532x626-png.png https://www.healthcarefocusminnesota.com/article/910895315-orasure-announces-first-quarter-2026-financial-results Healthcare Focus Minnesota en PressRelease 2026-05-06T20:05:00+00:00 OraSure Announces First Quarter 2026 Financial Results https://ml.globenewswire.com/media/713ef28e-6d0b-4156-a92f-397061b474cf/small/oti-wordmark-png.png https://www.healthcarefocusminnesota.com/article/910895317-lyell-immunopharma-reports-business-highlights-and-financial-results-for-the-first-quarter-2026 Healthcare Focus Minnesota en PressRelease 2026-05-06T20:05:00+00:00 Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026 https://ml.globenewswire.com/media/fa4a7bb1-f8ea-45e7-ba51-37077689a4fb/small/lyell-branding-color-rgb-102918a-copy-jpg.jpg https://www.healthcarefocusminnesota.com/article/910895418-adma-biologics-reports-first-quarter-2026-financial-results-and-provides-business-update Healthcare Focus Minnesota en PressRelease 2026-05-06T20:05:00+00:00 ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg https://www.healthcarefocusminnesota.com/article/910895497-tenaya-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update Healthcare Focus Minnesota en PressRelease 2026-05-06T20:05:00+00:00 Tenaya Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/95a7de9f-2b24-4ff3-9b57-f8a35e8c049f/small/tenaya-logo-fullcolor-rgb-jpg.jpg https://www.healthcarefocusminnesota.com/article/910895540-billiontoone-reports-first-quarter-2026-results-and-raises-2026-revenue-guidance Healthcare Focus Minnesota en PressRelease 2026-05-06T20:05:00+00:00 BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance https://ml.globenewswire.com/media/888ae54a-648f-4986-998b-84df416858c7/small/billion-to-one-logo-new-jpg.jpg https://www.healthcarefocusminnesota.com/article/910895557-pennant-reports-first-quarter-2026-results Healthcare Focus Minnesota en PressRelease 2026-05-06T20:05:00+00:00 Pennant Reports First Quarter 2026 Results https://ml.globenewswire.com/media/d50f543c-fc54-437d-8007-600644587dfe/small/pennant-logo-png.png https://www.healthcarefocusminnesota.com/article/910895665-revolution-medicines-reports-first-quarter-2026-financial-results-and-update-on-corporate-progress Healthcare Focus Minnesota en PressRelease 2026-05-06T20:02:00+00:00 Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://www.healthcarefocusminnesota.com/article/910894780-argenx-announces-results-of-annual-general-meeting-and-board-of-directors-appointment-of-karen-massey-as-chief-executive-officer Healthcare Focus Minnesota en PressRelease 2026-05-06T20:01:00+00:00 argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png https://www.healthcarefocusminnesota.com/article/910894802-galapagos-reports-first-quarter-2026-financial-results-and-provides-business-update Healthcare Focus Minnesota en PressRelease 2026-05-06T20:01:00+00:00 Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update https://ml-eu.globenewswire.com/media/13b034e2-76d4-408b-bffb-c80d85420b03/small/microsoftteams-image-24-png.png https://www.healthcarefocusminnesota.com/article/910894818-galapagos-rapporteert-financi-le-resultaten-over-het-eerste-kwartaal-van-2026-en-geeft-bedrijfsupdate Healthcare Focus Minnesota en PressRelease 2026-05-06T20:01:00+00:00 Galapagos rapporteert financiële resultaten over het eerste kwartaal van 2026 en geeft bedrijfsupdate   https://ml-eu.globenewswire.com/media/13b034e2-76d4-408b-bffb-c80d85420b03/small/microsoftteams-image-24-png.png https://www.healthcarefocusminnesota.com/article/910894845-syndax-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Healthcare Focus Minnesota en PressRelease 2026-05-06T20:01:00+00:00 Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/399a65b5-bd4f-4ba5-980b-f4d0af9ae6a0/small/syndax-logo-jpg.jpg https://www.healthcarefocusminnesota.com/article/910894868-bridgebio-to-participate-in-may-and-june-investor-conferences Healthcare Focus Minnesota en PressRelease 2026-05-06T20:01:00+00:00 BridgeBio to Participate in May and June Investor Conferences https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://www.healthcarefocusminnesota.com/article/910894968-journey-medical-corporation-to-announce-first-quarter-2026-financial-results-on-may-13-2026 Healthcare Focus Minnesota en PressRelease 2026-05-06T20:01:00+00:00 Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026 https://ml.globenewswire.com/media/68f0b467-248f-4250-9cda-2c7a68a11a1d/small/journeylogo-1-jpg.jpg https://www.healthcarefocusminnesota.com/article/910895335-new-2-year-data-from-pivotal-approach-trial-of-transcon-cnp-navepegritide-show-pronounced-gains-in-growth-outcomes-in-children-with-achondroplasia Healthcare Focus Minnesota en PressRelease 2026-05-06T20:01:00+00:00 New 2-Year Data from Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) Show Pronounced Gains in Growth Outcomes in Children with Achondroplasia Aged ≥5 Years https://ml.globenewswire.com/media/b4b7c29a-478e-4a8e-b23b-b6a1cb18aee8/small/ascendis-final-logo-7-23-15-png.png https://www.healthcarefocusminnesota.com/article/910895600-mannkind-reports-first-quarter-2026-financial-results-and-provides-business-update Healthcare Focus Minnesota en PressRelease 2026-05-06T20:01:00+00:00 MannKind Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/fc4da88e-772c-44f1-87a9-36ece175bc5b/small/mannkind-logo-rgb-1200x628-png.png https://www.healthcarefocusminnesota.com/article/910895623-teknova-reports-first-quarter-2026-financial-results Healthcare Focus Minnesota en PressRelease 2026-05-06T20:01:00+00:00 Teknova Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/b4992253-8b06-4ba7-93c8-e1f9938c6556/small/updated-teknova-logo-2023-png.png https://www.healthcarefocusminnesota.com/article/910895040-arcutis-announces-first-quarter-2026-financial-results-and-provides-business-update Healthcare Focus Minnesota en PressRelease 2026-05-06T20:00:00+00:00 Arcutis Announces First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/1b166f47-afb1-44f1-91be-2d73e97c0ec3/small/arcutis-logo-png.png https://www.healthcarefocusminnesota.com/article/910895531-recovery-first-treatment-center-launches-innovative-music-program-where-creative-expression-including-songwriting-supports-recovery Healthcare Focus Minnesota en PressRelease 2026-05-06T20:00:00+00:00 Recovery First Treatment Center Launches Innovative Music Program Where Creative Expression, Including Songwriting, Supports Recovery https://ml.globenewswire.com/media/df400593-a7d2-41cb-b191-5bd00f158da8/small/recovery-first-logo-jpg.jpg https://www.healthcarefocusminnesota.com/article/910895561-fda-expands-ai-capabilities-and-completes-data-platform-consolidation Healthcare Focus Minnesota en PressRelease 2026-05-06T19:42:23+00:00 FDA Expands AI Capabilities and Completes Data Platform Consolidation https://ml.globenewswire.com/media/OWJmNDdkNmQtMzYxZS00MzlhLWJkMTctNjkyOTM2M2I1MjFmLTUwMDE1NDE1NC0yMDI2LTA1LTA2LWVu/tiny/FDA.png https://www.healthcarefocusminnesota.com/article/910881420-fda-launches-one-day-inspectional-assessments-to-strengthen-and-expand-oversight Healthcare Focus Minnesota en PressRelease 2026-05-06T19:33:03+00:00 FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight https://ml.globenewswire.com/media/NTc4OGM2M2MtMTQxYS00NzA5LWJlOWUtNDM4MTA5YmI1OWFhLTUwMDE1NDE1NC0yMDI2LTA1LTA2LWVu/tiny/FDA.png https://www.healthcarefocusminnesota.com/article/910881272-betterguards-acquires-wearable-sports-tech-startup-nextiles Healthcare Focus Minnesota en PressRelease 2026-05-06T18:41:27+00:00 Betterguards Acquires Wearable Sports Tech Startup Nextiles https://ml.globenewswire.com/media/f9a07229-20f6-43f3-88fd-94b6dad4f8ae/small/bg-logo-png.png https://www.healthcarefocusminnesota.com/article/910855643-walmart-canada-and-children-s-miracle-network-rally-canadians-to-support-kids-health-kick-off-annual-fundraising-campaign Healthcare Focus Minnesota en PressRelease 2026-05-06T17:34:43+00:00 Walmart Canada and Children’s Miracle Network Rally Canadians to Support Kids’ Health, Kick Off Annual Fundraising Campaign https://ml.globenewswire.com/media/2098ebf6-0983-46f2-8989-a71b94ccd66a/small/lockup-cmn-walmart-png.png https://www.healthcarefocusminnesota.com/article/910855646-walmart-canada-et-children-s-miracle-network-mobilisent-les-canadiens-pour-soutenir-la-sant-des-enfants-et-donnent-le-coup-d-envoi-de-la-campagne Healthcare Focus Minnesota en PressRelease 2026-05-06T17:34:43+00:00 Walmart Canada et Children's Miracle Network mobilisent les Canadiens pour soutenir la santé des enfants et donnent le coup d’envoi de la campagne annuelle de collecte de fonds https://ml.globenewswire.com/media/2098ebf6-0983-46f2-8989-a71b94ccd66a/small/ https://www.healthcarefocusminnesota.com/article/910855616-diathrive-health-and-kardiacomplete-announce-strategic-partnership-to-address-cardiometabolic-risk Healthcare Focus Minnesota en PressRelease 2026-05-06T17:17:36+00:00 Diathrive Health and KardiaComplete Announce Strategic Partnership to Address Cardiometabolic Risk https://ml.globenewswire.com/media/ca97a5ad-9227-4559-a41a-59468d5bc246/small/alivecor.png https://www.healthcarefocusminnesota.com/article/910855216-renewa-micro-infusion-system-claims-evaluated-the-painless-skin-microneedling-device-for-at-home-face-lift-treatment Healthcare Focus Minnesota en PressRelease 2026-05-06T16:47:46+00:00 Renewa Micro-Infusion System Claims Evaluated: The Painless Skin Microneedling Device for At-Home Face Lift Treatment https://zingfast.com/wp-content/uploads/2026/05/Renewa-Micro-Infusion-System.jpg https://www.healthcarefocusminnesota.com/article/910844481-ehealth-exchange-earns-2026-klas-points-of-light-award-for-advancing-digital-quality-measurement-with-bulk-fhir Healthcare Focus Minnesota en PressRelease 2026-05-06T16:26:00+00:00 eHealth Exchange Earns 2026 KLAS Points of Light Award for Advancing Digital Quality Measurement with Bulk FHIR https://ml.globenewswire.com/media/8cc7b0d1-2d24-41da-b3bc-54e9953144ee/small/ehealth-logo-png.png https://www.healthcarefocusminnesota.com/article/910844278-paremina-selected-as-preferred-brand-for-swiss-longevity-supplements-in-luxury-hospitality Healthcare Focus Minnesota en PressRelease 2026-05-06T16:19:00+00:00 Paremina selected as Preferred Brand for Swiss Longevity Supplements in Luxury Hospitality https://pressranger.s3.us-west-1.amazonaws.com/3255602/paremina-banner.jpg https://www.healthcarefocusminnesota.com/article/910844105-sage-dental-expands-national-reach-through-strategic-partnership-with-curaechoice Healthcare Focus Minnesota en PressRelease 2026-05-06T16:07:00+00:00 Sage Dental Expands National Reach Through Strategic Partnership with Curaechoice https://ml.globenewswire.com/media/a74a7291-6b73-4b11-8a1a-4544f792b484/small/screenshot-2025-11-04-at-10-27-29-am-png.png https://www.healthcarefocusminnesota.com/article/910844035-carbogen-amcis-shanghai-site-achieves-successful-outcome-in-unannounced-nmpa-gmp-inspection Healthcare Focus Minnesota en PressRelease 2026-05-06T16:04:06+00:00 CARBOGEN AMCIS Shanghai Site achieves successful outcome in Unannounced NMPA GMP Inspection https://ml-eu.globenewswire.com/media/fb9efd55-1cdf-42ee-96bb-60d199a0683d/medium/carbogen-amcis-shanghai.jpg https://www.healthcarefocusminnesota.com/article/910831823-robotic-companion-pets-from-ageless-innovation-reach-750-000-adoptions-supporting-well-being-for-older-adults Healthcare Focus Minnesota en PressRelease 2026-05-06T15:27:48+00:00 Robotic Companion Pets from Ageless Innovation Reach 750,000 Adoptions Supporting Well-Being for Older Adults https://ml.globenewswire.com/media/27dc8195-26bc-4a35-9909-ab9e10b37803/small/ageless-innovation-logo-png.png https://www.healthcarefocusminnesota.com/article/910831628-trethera-to-present-optic-neuritis-research-at-los-angeles-bioscience-ecosystem-summit-2026 Healthcare Focus Minnesota en PressRelease 2026-05-06T15:25:00+00:00 Trethera To Present Optic Neuritis Research at Los Angeles Bioscience Ecosystem Summit 2026 https://ml.globenewswire.com/media/58f1dd8e-4737-42db-950e-17f8d4a0a486/medium/fig-1.png https://www.healthcarefocusminnesota.com/article/910831720-nearly-half-of-americans-are-aware-of-the-new-dietary-guidelines-for-americans-new-food-pyramid-within-weeks-of-their-debut Healthcare Focus Minnesota en PressRelease 2026-05-06T14:55:43+00:00 Nearly Half Of Americans Are Aware Of The New Dietary Guidelines for Americans & New Food Pyramid Within Weeks Of Their Debut https://ml.globenewswire.com/media/MWIwMGYyZGYtZjY0OS00YTdjLWFjMDktOWI0Y2JkMGZmNmQzLTEwOTg2ODEtMjAyNi0wNS0wNi1lbg==/tiny/International-Food-Information.png https://www.healthcarefocusminnesota.com/article/910820002-becoming-independent-celebrates-outstanding-individuals-and-partners-at-second-annual-spotlight-awards Healthcare Focus Minnesota en PressRelease 2026-05-06T14:00:00+00:00 Becoming Independent Celebrates Outstanding Individuals and Partners at Second Annual Spotlight Awards https://ml.globenewswire.com/media/bd5bec97-a0fe-41ab-8908-7c2fdc06d56d/medium/advocate-of-the-year-erik-son-nancy-mietz-mother.jpg https://www.healthcarefocusminnesota.com/article/910820065-twentyeight-health-partners-with-ura-to-expand-access-to-comprehensive-contraceptive-care Healthcare Focus Minnesota en PressRelease 2026-05-06T13:50:00+00:00 Twentyeight Health Partners with ŌURA to Expand Access to Comprehensive Contraceptive Care https://ml.globenewswire.com/media/ab364761-0cc6-4c5e-9483-815a4f74e08a/small/twentyeight-health-logo-jpg.jpg https://www.healthcarefocusminnesota.com/article/910808741-better-blend-continues-growth-with-second-lexington-location Healthcare Focus Minnesota en PressRelease 2026-05-06T13:40:01+00:00 Better Blend Continues Growth with Second Lexington Location https://ml.globenewswire.com/media/b9ef98e3-35e0-407c-a76c-27dedd72308f/medium/better-blend-mobile-pick-up-lane.jpg https://www.healthcarefocusminnesota.com/article/910808739-american-kidney-fund-and-akf-ambassadors-on-capitol-hill-for-annual-akf-kidney-action-summit Healthcare Focus Minnesota en PressRelease 2026-05-06T13:25:11+00:00 American Kidney Fund and AKF Ambassadors on Capitol Hill for Annual AKF Kidney Action Summit https://ml.globenewswire.com/media/MjEwYTRjNTgtYjJhZS00ZjFkLThmM2QtOTY3ZjMyMTQ3MDYzLTExMDkwNTItMjAyNi0wNS0wNi1lbg==/tiny/American-Kidney-Fund.png https://www.healthcarefocusminnesota.com/article/910808605-american-nurses-enterprise-kicks-off-national-nurses-week-celebrations Healthcare Focus Minnesota en PressRelease 2026-05-06T13:11:26+00:00 American Nurses Enterprise Kicks Off National Nurses Week Celebrations https://ml.globenewswire.com/media/NzE3N2RjNmMtODY3Ny00NjRkLWE4NTAtOTkwYzUxNzFlMzY2LTUwMDE2MTk2Mi0yMDI2LTA1LTA2LWVu/tiny/American-Nurses-Enterprise.png https://www.healthcarefocusminnesota.com/article/910808594-joint-commission-and-nachc-announce-strategic-partnership-to-support-community-health-centers-and-patients Healthcare Focus Minnesota en PressRelease 2026-05-06T13:06:53+00:00 Joint Commission and NACHC Announce Strategic Partnership to Support Community Health Centers and Patients https://ml.globenewswire.com/media/ZGE0OGM2NWEtNmYyNi00OWJjLWFjYmMtMTExNDUxYzlkNDIzLTUwMDE1ODA0Ny0yMDI2LTA1LTA2LWVu/tiny/Joint-Commission.png https://www.healthcarefocusminnesota.com/article/910808189-tekton-research-appoints-dr-amit-vijapura-as-central-nervous-system-key-opinion-leader Healthcare Focus Minnesota en PressRelease 2026-05-06T13:05:00+00:00 Tekton Research Appoints Dr. Amit Vijapura as Central Nervous System Key Opinion Leader https://ml.globenewswire.com/media/3de70544-645a-462a-b864-880c614f0792/small/logo-tekton-png.png https://www.healthcarefocusminnesota.com/article/910808546-hope-air-marks-40-years-of-changing-health-outcomes-for-patients-needing-to-travel-long-distances-for-care Healthcare Focus Minnesota en PressRelease 2026-05-06T13:05:00+00:00 Hope Air Marks 40 Years of Changing Health Outcomes for Patients Needing to Travel Long Distances for Care https://ml.globenewswire.com/media/d3681ff3-0b3f-4075-9888-0309ed73c339/small/hope-air-logo-png.png https://www.healthcarefocusminnesota.com/article/910808179-jito-foundation-and-solana-company-nasdaq-hsdt-announce-strategic-partnership-to-expand-institutional-solana-infrastructure-across-asia-pacific Healthcare Focus Minnesota en PressRelease 2026-05-06T13:00:00+00:00 Jito Foundation and Solana Company (NASDAQ: HSDT) Announce Strategic Partnership to Expand Institutional Solana Infrastructure Across Asia-Pacific Region https://ml.globenewswire.com/media/1986b97e-8656-4213-9218-ae51324d696d/small/solana-company-main-black-png.png https://www.healthcarefocusminnesota.com/article/910808363-medwell-ai-inc-reports-q3-revenues-of-618-676-and-provides-corporate-update Healthcare Focus Minnesota en PressRelease 2026-05-06T13:00:00+00:00 MedWell Ai, Inc Reports Q3 Revenues Of $618,676 And Provides Corporate Update https://ml.globenewswire.com/media/20f2b978-0b1a-4796-8177-6c597fd8e4c2/small/mwai-png.png https://www.healthcarefocusminnesota.com/article/910808475-nexgel-appoints-brian-kieser-and-kevin-harris-from-new-strategic-partner-sequence-lifescience-to-board-of-directors Healthcare Focus Minnesota en PressRelease 2026-05-06T13:00:00+00:00 NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors https://ml.globenewswire.com/media/0e76fff8-7aee-4b60-ba26-62dda9975939/small/logo-png.png https://www.healthcarefocusminnesota.com/article/910808510-bioadaptives-inc-launches-myndrenew-to-complete-the-24-hour-brain-performance-cycle Healthcare Focus Minnesota en PressRelease 2026-05-06T12:54:00+00:00 BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle https://ml.globenewswire.com/media/ad289631-6a2e-4b27-bc43-6b7ac688a537/small/bioadaptives-logo-jpg.jpg https://www.healthcarefocusminnesota.com/article/910808159-actuate-therapeutics-announces-key-appointment-of-industry-veteran-to-board-of-directors Healthcare Focus Minnesota en PressRelease 2026-05-06T12:45:00+00:00 Actuate Therapeutics Announces Key Appointment of Industry Veteran to Board of Directors https://ml.globenewswire.com/media/f65ca94c-eff8-4376-ac67-ded1b03b3bcc/small/actuatetx-logo-color300-jpg.jpg https://www.healthcarefocusminnesota.com/article/910796897-latest-pharmaceutical-suppositories-market-size-to-hit-usd-13-4-bn-at-a-cagr-of-3-5-by-2034-report-by-zion-market-research Healthcare Focus Minnesota en PressRelease 2026-05-06T12:41:14+00:00 [Latest] Pharmaceutical Suppositories Market Size to Hit USD 13.4 Bn at a CAGR of 3.5% by 2034 - Report by Zion Market Research https://ml.globenewswire.com/media/1f4cf0ab-7d76-4136-a6dc-a5545f80f538/small/zion-market-research-jpg.jpg https://www.healthcarefocusminnesota.com/article/910796652-where-executives-are-doubling-down-on-their-companies-fortunes Healthcare Focus Minnesota en PressRelease 2026-05-06T12:35:00+00:00 Where Executives Are Doubling Down on Their Companies’ Fortunes https://ml.globenewswire.com/media/1f91276c-d820-4666-8efc-2d8786490903/small/neonc-technologies-holding-logo-vector-png.png https://www.healthcarefocusminnesota.com/article/910796841-ernexa-therapeutics-unveils-breakthrough-preclinical-results-erna-101-achieves-100-survival-and-complete-tumor-elimination-in-ovarian-cancer-models Healthcare Focus Minnesota en PressRelease 2026-05-06T12:33:00+00:00 Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models https://ml.globenewswire.com/media/bb12f9ec-b7e7-4d8c-92df-cf27e238c398/small/ernexa-color-png.png https://www.healthcarefocusminnesota.com/article/910795980-bioxodes-presents-positive-final-phase-2a-intracerebral-hemorrhage-results-at-esoc-affirming-breakthrough-potential-of-biox-101 Healthcare Focus Minnesota en PressRelease 2026-05-06T12:30:00+00:00 Bioxodes presents positive final Phase 2a intracerebral hemorrhage results at ESOC affirming breakthrough potential of BIOX-101 https://ml-eu.globenewswire.com/media/11568637-8587-499f-8472-d6009ae7d0ba/small/bioxodes-logo-fond-transparent-png.png https://www.healthcarefocusminnesota.com/article/910796094-pliant-therapeutics-to-participate-in-the-rbc-capital-markets-global-healthcare-conference Healthcare Focus Minnesota en PressRelease 2026-05-06T12:30:00+00:00 Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg https://www.healthcarefocusminnesota.com/article/910796098-veru-to-report-fiscal-2026-second-quarter-financial-results-on-may-13th Healthcare Focus Minnesota en PressRelease 2026-05-06T12:30:00+00:00 Veru to Report Fiscal 2026 Second Quarter Financial Results on May 13th https://ml.globenewswire.com/media/9c96f1a7-e104-47d4-8011-8c19496681c2/small/final-veruinclogo-rgb-300dpi-jpg.jpg https://www.healthcarefocusminnesota.com/article/910796167-allogene-therapeutics-to-report-first-quarter-financial-results-and-provide-business-update Healthcare Focus Minnesota en PressRelease 2026-05-06T12:30:00+00:00 Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update https://ml.globenewswire.com/media/87e8712c-0741-409f-9942-c91b31e7c5e1/small/allogene-png.png https://www.healthcarefocusminnesota.com/article/910796329-cristcot-appoints-rayna-herman-as-president-of-its-hydrocortisone-acetate-commercial-division Healthcare Focus Minnesota en PressRelease 2026-05-06T12:30:00+00:00 Cristcot Appoints Rayna Herman as President of its Hydrocortisone Acetate Commercial Division https://ml.globenewswire.com/media/ODc0YjM4OTItZWNkZi00ZWU2LThmY2QtYTFhZGNiMmFjMTE4LTEzMjI0MTAtMjAyNi0wNS0wNi1lbg==/tiny/Cristcot-LLC.png https://www.healthcarefocusminnesota.com/article/910796657-oncotelic-therapeutics-announces-closing-of-a-strategic-monetization-of-its-cns-nasal-assets-with-lunai-bioworks-advancing-joint-development-in Healthcare Focus Minnesota en PressRelease 2026-05-06T12:30:00+00:00 Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease https://ml.globenewswire.com/media/aa650511-a1c3-496e-803a-448d7f8d409a/small/picture1-jpg.jpg https://www.healthcarefocusminnesota.com/article/910796713-cdt-advances-azd5904-into-global-patent-phase-and-initiates-partnering-discussions Healthcare Focus Minnesota en PressRelease 2026-05-06T12:30:00+00:00 CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions https://ml.globenewswire.com/media/Y2YxYWQ5NTgtMDg3ZC00NGRlLTlkMmItODk2Zjk4YTAxYTg4LTEyNzQxMDItMjAyNi0wNS0wNi1lbg==/tiny/CDT-Equity-Inc-.png https://www.healthcarefocusminnesota.com/article/910796774-crispr-therapeutics-to-present-at-the-bank-of-america-securities-2026-global-healthcare-conference Healthcare Focus Minnesota en PressRelease 2026-05-06T12:30:00+00:00 CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference https://ml.globenewswire.com/media/5dac7d0d-131d-4047-bab7-db8e0719bf58/small/crispr-logo-jpg.jpg https://www.healthcarefocusminnesota.com/article/910796861-inflarx-announces-pricing-of-150-million-underwritten-offering-of-ordinary-shares Healthcare Focus Minnesota en PressRelease 2026-05-06T12:30:00+00:00 InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png https://www.healthcarefocusminnesota.com/article/910796856-inflarx-announces-advancement-of-izicopan-in-anca-associated-vasculitis-and-select-renal-diseases Healthcare Focus Minnesota en PressRelease 2026-05-06T12:25:00+00:00 InflaRx Announces Advancement of Izicopan in ANCA-Associated Vasculitis and Select Renal Diseases https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png https://www.healthcarefocusminnesota.com/article/910796721-scienture-announces-third-patent-grant-for-arbli-losartan-potassium-oral-suspension-strengthening-long-term-market-exclusivity-through-2041 Healthcare Focus Minnesota en PressRelease 2026-05-06T12:05:00+00:00 SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041 https://ml.globenewswire.com/media/492f1bb3-8792-47f3-81e5-15dd04df46b4/small/logo-png.png https://www.healthcarefocusminnesota.com/article/910796254-orchestra-biomed-receives-15-million-investment-from-ligand-under-previously-announced-strategic-financing-agreement Healthcare Focus Minnesota en PressRelease 2026-05-06T12:01:00+00:00 Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement https://ml.globenewswire.com/media/00697d05-bd34-4570-822b-f204caf21694/small/ogsk2sgeyptxenjnnf5a-png.png https://www.healthcarefocusminnesota.com/article/910796015-aktis-oncology-to-present-at-the-bofa-securities-health-care-conference Healthcare Focus Minnesota en PressRelease 2026-05-06T12:00:00+00:00 Aktis Oncology to Present at the BofA Securities Health Care Conference https://ml.globenewswire.com/media/490bbb9a-2b27-4a72-8d7a-333387326d8b/small/aktis-rgb-png.png https://www.healthcarefocusminnesota.com/article/910796024-abli-therapeutics-appoints-industry-veteran-dr-rachelle-s-doody-to-its-board-of-directors Healthcare Focus Minnesota en PressRelease 2026-05-06T12:00:00+00:00 ABLi Therapeutics Appoints Industry Veteran Dr. Rachelle S. Doody to its Board of Directors https://ml.globenewswire.com/media/b771ed66-3175-44f5-be35-7c3c380f64a1/small/abli-tx-jpg.jpg https://www.healthcarefocusminnesota.com/article/910796040-annexon-to-present-at-the-bank-of-america-securities-health-care-conference-2026 Healthcare Focus Minnesota en PressRelease 2026-05-06T12:00:00+00:00 Annexon to Present at the Bank of America Securities Health Care Conference 2026 https://ml.globenewswire.com/media/fda933a1-e95d-4cae-8894-7b2354118e20/small/annexon-logo-rgb-png.png https://www.healthcarefocusminnesota.com/article/910796051-in8bio-to-showcase-next-generation-t-cell-engager-platform-and-new-clinical-data-at-upcoming-r-d-day-and-medical-conferences Healthcare Focus Minnesota en PressRelease 2026-05-06T12:00:00+00:00 IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences https://ml.globenewswire.com/media/ab4056e8-16d0-4c44-9ee8-367a47f6ef78/small/in8biologo-jpg.jpg https://www.healthcarefocusminnesota.com/article/910796111-pathos-ai-acquires-majority-stake-in-deuteroncology-to-advance-next-generation-met-inhibitor-identified-by-pathos-foundry-platform Healthcare Focus Minnesota en PressRelease 2026-05-06T12:00:00+00:00 Pathos AI Acquires Majority Stake in DeuterOncology to Advance Next-Generation MET Inhibitor Identified by Pathos Foundry Platform https://ml.globenewswire.com/media/3a9007f6-d394-44fa-adf5-606bbb9d5d85/small/pr-image-png.png https://www.healthcarefocusminnesota.com/article/910796113-milestone-pharmaceuticals-to-announce-first-quarter-2026-financial-results-on-may-13-2026 Healthcare Focus Minnesota en PressRelease 2026-05-06T12:00:00+00:00 Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026 https://ml.globenewswire.com/media/49b2e16b-2deb-4c9e-9c20-6cc4fd6c15ab/small/milestone-pharmaceuticals-logo-png.png https://www.healthcarefocusminnesota.com/article/910796168-taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update Healthcare Focus Minnesota en PressRelease 2026-05-06T12:00:00+00:00 Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/a88cd5f5-0b05-416c-a56b-e4130c10cfca/small/new-taysha-inline-fullcolor-rgb-12in-300ppi-jpg.jpg https://www.healthcarefocusminnesota.com/article/910796216-rhythm-pharmaceuticals-announces-participation-in-upcoming-bank-of-america-global-healthcare-conference Healthcare Focus Minnesota en PressRelease 2026-05-06T12:00:00+00:00 Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://www.healthcarefocusminnesota.com/article/910796223-orchestra-biomed-receives-20-million-payment-from-medtronic-under-previously-announced-financing-agreement Healthcare Focus Minnesota en PressRelease 2026-05-06T12:00:00+00:00 Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement https://ml.globenewswire.com/media/00697d05-bd34-4570-822b-f204caf21694/small/ogsk2sgeyptxenjnnf5a-png.png